Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.

Motonobu HamazakiTsunaki SawadaTakeshi YamamuraKeiko MaedaYasuyuki MizutaniEri IshikawaSatoshi FuruneKenta YamamotoTakuya IshikawaNaomi KakushimaKazuhiro FurukawaEizaburo OhnoTakashi HondaHiroki KawashimaMasatoshi IshigamiMasanao NakamuraMitsuhiro Fujishiro

Published in: BMC gastroenterology (2022)

This study was registered in the University Hospital Medical Information Network Clinical Trial Registration (UMIN000026363). Registered 31 May 2017, https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000026363 . The study was registered prospectively.

Keyphrases

clinical trial
irritable bowel syndrome
study protocol
phase ii
phase iii
mesenchymal stem cells
health information
replacement therapy